Recent studies have clarified that STAT3 regulates the expression of PD-L1 in antigen-presenting cells as well as in a number of tumor cells, including lung cancer and melanoma, to inhibit the tumor immune response [21, 68]. The gene discussed is STAT3; the disease is neoplasm.